Clinical Trials in San Francisco

Showing 9321-9340 of 9,883 trials

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

NCT00040677

ICA-17043 is being developed for the chronic treatment of patients with sickle cell disease (SCD) in both adults and children. ICA-17043 is a potent and specific inhibitor of a channel in human red blood cells (RBCs) that blocks RBC dehydration. ICA-17043 is expected to inhibit RBC dehydration and thus should prevent or delay the sickling process. By reducing sickled cells, an improvement in anemia, a reduction in painful crises, and ultimately, less end-organ disease is anticipated.

Sickle Cell DiseaseSickle Cell Anemia

Icagen90 participantsStarted Feb 2002

Birmingham, Alabama, United States • Oakland, California, United States • San Francisco, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if this treatment can improve the time to disease progression.

MelanomaMetastatic MelanomaMalignant Melanoma+1 more

Vical133 participantsStarted Feb 2001

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +13 more locations

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Find Trials by Condition in San Francisco

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

A Multiple Myeloma Trial in Patients With Bone Metastases

Alternative Support for Rural and Isolated Women in an HMO

Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

A Study for Patients With Type 2 Diabetes Mellitus

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine

DPBRN Reasons for Replacement or Repair of Dental Restorations

DPBRN Blood Sugar Testing in Dental Patients

Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial